Synonyms: ACP-044 | ACP044 | compound 1 [WO2020159643A1] [1]
Compound class:
Synthetic organic
Comment: The chemical structure for ebaresdax is claimed in Cersci Therapeutics' patent WO2020159643A1 [1], which allowed us to associate this structure with their clinical lead candidate ACP-044. This was confirmed by synonym matches on PubChem. Ebaresdax (ACP-044) is a first-in-class, orally administered, non-opioid analgesic that was developed for potential to treat neuropathic, surgical and osteoarthritic pain.
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
(4R)-2-(2-hydroxyanilino)-5,5-dimethyl-4H-1,3-thiazole-4-carboxylic acid |
International Nonproprietary Names | |
INN number | INN |
11566 | ebaresdax |
Synonyms | |
ACP-044 | ACP044 | compound 1 [WO2020159643A1] [1] |
Database Links | |
CAS Registry No. | 1334471-39-4 (source: WHO INN record) |
GtoPdb PubChem SID | 472319271 |
PubChem CID | 53362112 |
Search Google for chemical match using the InChIKey | OASISJWJIHWVKX-SECBINFHSA-N |
Search Google for chemicals with the same backbone | OASISJWJIHWVKX |
Search PubMed clinical trials | ebaresdax |
Search PubMed titles | ebaresdax |
Search PubMed titles/abstracts | ebaresdax |
UniChem Compound Search for chemical match using the InChIKey | OASISJWJIHWVKX-SECBINFHSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | OASISJWJIHWVKX-SECBINFHSA-N |